Knowledge

Bavarian Nordic

Source 📝

29: 1739: 280: 261: 240: 219: 1094: 469:
to develop and manufacture this vaccine regimen intended for emergency use to help contain the outbreak in West Africa. In January 2015, the company had produced the first 400,000 doses of the vaccine and the first clinical trial of the vaccine regimen was initiated in the UK, with additional trials
654:
Acquisition completed on 31 December 2019. Bavarian Nordic assumes full sales and marketing responsibility from start 2020; manufacturing transfer takes place 2020–25 – during this period Bavarian Nordic will purchase remaining inventory of vaccines from GSK at different levels in the supply chain.
635:
Acquisition completed on 31 December 2019. Bavarian Nordic assumes full sales and marketing responsibility from start 2020; manufacturing transfer takes place 2020–25 – during this period Bavarian Nordic will purchase remaining inventory of vaccines from GSK at different levels in the supply chain.
456:
diseases. In October 2014, following a successful pre-clinical demonstration of the combination vaccine regimen of its multivalent MVA-BN Filovirus vaccine and Crucell/Janssen's AdVac technology based on adenoviral vectors, Bavarian Nordic joined efforts with
1033: 732:, a group of companies, academic institutions, and other organizations dedicated to building an effective medical countermeasure enterprise through sound public policy and strong public-private partnerships. 1144:
Greenberg RN, Hay CM, Stapleton JT, Marbury TC, Wagner E, Kreitmeir E, Röesch S, von Krempelhuber A, Young P, Nichols R, Meyer TP, Schmidt D, Weigl J, Virgin G, Arndtz-Wiedemann N, Chaplin P (2016).
1146:"A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN) in 56-80-Year-Old Subjects" 1601: 729: 1668: 1917: 1300: 1705: 1334: 1404: 1045: 999: 1429: 1278: 458: 1932: 1727: 1116: 782: 1927: 1902: 908: 390:-based vaccines, which may replicate in humans, thus potentially causing severe and life-threatening side effects. Developed as the non-replicating 331: 1912: 83: 1735: 1922: 1122: 1937: 1655: 827: 1907: 1897: 1476: 1203:
Exclusive: Closure of World's Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World's Ability to Meet Rising Demand
1308: 1720: 1240: 760: 1214: 878: 1079: 796: 1379: 1713: 1356: 1633: 1628: 736: 1011: 709: 318:
company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in
1330: 1509:"Bavarian Nordic Reports Positive Phase 3 Topline Results for Chikungunya Virus Vaccine in Adults and Adolescents" 1574: 1202: 1553:"Bavarian Nordic Announces Topline Results from Phase 1 Clinical Trial of Equine Encephalitis Virus Vaccine" 1266: 478:
In October 2019, it was announced that Bavarian Nordic would acquire travel vaccines Rabipur(/Rabavert) for
1073: 419: 915: 362: 157: 1530: 717:
Ph1 topline results announced 8 June 2020. A Phase 2 clinical study is planned for initiation in 2024.
429:, leading to concerns over vaccine nationalism and hoarding by countries with pre-existing contracts. 60: 1430:"Bavarian Nordic scoops up Emergent's travel vaccines, manufacturing site in deal worth up to $ 380M" 1357:"Johnson & Johnson Announces European Commission Approval for Janssen's Preventive Ebola Vaccine" 1041: 946: 1552: 1508: 1663: 740: 383: 470:
planned in the US and Africa. It was approved for medical use in the European Union in July 2020.
1111: 645: 483: 462: 453: 426: 161: 831: 1851: 386:
virus. MVA-BN is characterized by the inability to replicate in human cells, contrary to other
1483: 1596: 1241:"Bavarian Nordic Enters Licensing and Supply Agreement with Janssen on MVA-BN® Ebola Vaccine" 507: 490:(GSK). In February 2023, it was announced that Bavarian Nordic would acquire travel vaccines 450: 682: 678: 660: 567: 540: 207: 1454: 1405:"GSK agrees to divest rabies and tick-borne encephalitis vaccines to Bavarian Nordic | GSK" 1157: 585: 466: 1244: 8: 446: 1876: 1218: 1161: 886: 853: 382:
MVA-BN is a proprietary technology developed by Bavarian Nordic. It is derived from the
1180: 1145: 1067: 981: 968: 941: 701:
Ph3 topline results announced 6 August 2023. Regulatory submissions planned for 2024.
1846: 1743: 1185: 973: 776: 72: 65: 1623: 985: 1175: 1165: 963: 955: 807: 253: 336: 1776: 1170: 487: 89: 1871: 1761: 530: 407: 76: 39: 1891: 1856: 1811: 1801: 1098: 1007: 942:"IMVAMUNE: modified vaccinia Ankara strain as an attenuated smallpox vaccine" 669: 495: 315: 100: 56: 47: 959: 1836: 1189: 977: 681:(Ad26.ZEBOV) followed 8 weeks later by a dose of Bavarian Nordic's booster 366: 265: 244: 223: 327: 1831: 1791: 1781: 693: 503: 358: 346: 685:(MVA-BN Filo) collectively constitutes Janssen's Ebola vaccine regimen. 1821: 28: 345:, Switzerland. The company has research and development facilities in 1841: 1786: 1331:"J&J, Bavarian Nordic start clinical tests in Ebola vaccine race" 594: 442: 395: 610: 590: 572: 553: 545: 518:
Bavarian Nordic's marketed products and pipeline, as of July 2020.
403: 391: 387: 319: 203: 191: 179: 150: 129: 1698: 1826: 1816: 1747: 1738: 1304: 1274: 1097:
This article incorporates text from this source, which is in the
901: 499: 415: 411: 350: 323: 199: 195: 187: 183: 175: 1866: 1806: 1796: 1766: 627: 479: 399: 292: 665: 491: 438: 232: 1267:"BRIEF-Bavarian Nordic to expand collaboration with Janssen" 1143: 1861: 549: 432: 342: 1010:. 13 June 2014. 144762 (Submission Number). Archived from 369:
and virus-like particles in its research and development.
354: 1918:
Companies traded over-the-counter in the United States
425:
The vaccine is being deployed worldwide to combat the
1117:
National Institute of Allergy and Infectious Diseases
418:. The vaccine was supplied for emergency use to the 1380:"GSK to divest Rabipur, Encepur to Bavarian Nordic" 1307:. Associated Press. 22 October 2014. Archived from 1301:"Johnson & Johnson plans Ebola vaccine testing" 1243:. Bavarian Nordic. 22 October 2014. Archived from 677:Licensed to Janssen. One dose of Janssen's primer 437:The company has worked for several years with the 513: 353:and San Diego, California, as well as offices in 1889: 939: 781:: CS1 maint: bot: original URL status unknown ( 1721: 822: 820: 763:. Archived from the original on 13 March 2022 1933:Pharmaceutical companies established in 1994 1000:"Products for Human Use. Submission #144762" 992: 502:, in addition to a late-stage candidate for 940:Kennedy JS, Greenberg RN (9 January 2014). 1928:Life science companies based in Copenhagen 1728: 1714: 817: 1179: 1169: 967: 1903:Companies based in Gentofte Municipality 1215:"Infectious Diseases: Filovirus Vaccine" 1112:"Smallpox Vaccine Supply & Strength" 735:The company is a funding partner of the 626:(Pre-/post-exposure protection against) 433:Ebola vaccine development and production 422:as well as other government stockpiles. 1890: 1913:Companies listed on Nasdaq Copenhagen 1709: 1477:"Annual Report 2019, Pipeline (p.30)" 1377: 1923:Danish companies established in 1994 1337:from the original on 13 January 2015 1281:from the original on 30 October 2014 1125:from the original on 17 October 2019 1082:from the original on 17 October 2019 1938:Pharmaceutical companies of Denmark 1629:Bipartisan Commission on Biodefense 1457:. Bavarian Nordic. 20 February 2020 737:Bipartisan Commission on Biodefense 728:Bavarian Nordic is a member of the 618:Phase 3 clinical trials completed. 326:, with manufacturing facilities in 13: 1908:Companies in the OMX Copenhagen 25 1898:Biotechnology companies of Denmark 1026: 14: 1949: 1690: 1602:Medical Countermeasures Coalition 1482:. Bavarian Nordic. Archived from 1217:. Bavarian Nordic. Archived from 1078:. 24 September 2019. STN 125678. 914:. Bavarian Nordic. Archived from 830:. Bavarian Nordic. Archived from 730:Medical Countermeasures Coalition 710:Western equine encephalitis virus 420:U.S. Strategic National Stockpile 1737: 1674:from the original on 7 July 2022 1636:from the original on 29 May 2022 1511:. Bavarian Nordic. 6 August 2023 1092: 279: 278: 260: 259: 239: 238: 218: 217: 27: 1648: 1616: 1589: 1567: 1545: 1523: 1501: 1469: 1447: 1422: 1397: 1378:Smith, Anna (21 October 2019). 1371: 1349: 1323: 1293: 1259: 1233: 1207: 1196: 1137: 1104: 1060: 797:"OMX Copenhagen 25 (OMXC25CAP)" 723: 473: 398:vaccine, MVA-BN is approved in 372: 303:Footnotes / references 1555:. Bavarian Nordic. 8 June 2020 933: 871: 846: 789: 753: 514:Marketed products and pipeline 1: 1044:. 27 May 2016. Archived from 746: 1171:10.1371/journal.pone.0157335 1074:Food and Drug Administration 1004:Register of Innovative Drugs 739:, and a former donor to the 7: 1333:. Reuters. 6 January 2015. 414:, and the United States as 363:Morrisville, North Carolina 112:; 30 years ago 10: 1954: 1757: 1042:European Medicines Agency 947:Expert Review of Vaccines 377: 301: 287: 272: 251: 230: 213: 171: 140: 124: 106: 96: 82: 45: 35: 26: 1664:Bipartisan Policy Center 741:Bipartisan Policy Center 441:on the development of a 384:Modified vaccinia Ankara 960:10.1586/14760584.8.1.13 646:tick-borne encephalitis 577:Approved Canada 2013-11 484:tick-borne encephalitis 463:Janssen Pharmaceuticals 1597:"Member Organizations" 1359:. Reuters. 1 July 2020 879:"Executive Management" 674:Approved EU 2020-07-01 599:Approved US 2019-09-24 552:and disease caused by 314:is a fully integrated 16:Pharmaceutical company 1575:"Equine Encephalitis" 1121:. 26 September 2019. 607:MVA-BN (freeze-dried) 508:Emergent BioSolutions 467:Johnson & Johnson 1656:"2017 Annual Report" 909:"Annual Report 2023" 854:"Board of Directors" 459:Crucell Holland B.V. 264:10.340 billion 243:14.373 billion 1867:Vestas Wind Systems 1624:"Sponsors / Donors" 1277:. 23 October 2014. 1162:2016PLoSO..1157335G 828:"Hellerup, Denmark" 644:European (Western) 559:Approved EU 2013-07 365:. The company uses 312:Bavarian Nordic A/S 274:Number of employees 222:7.062 billion 23: 22:Bavarian Nordic A/S 1311:on 31 October 2014 1247:on 3 November 2014 1221:on 30 October 2014 427:2022 mpox outbreak 21: 1885: 1884: 1767:A.P. Møller-Mærsk 1744:OMX Copenhagen 25 1577:. Bavarian Nordic 1533:. Bavarian Nordic 813:on 13 March 2022. 721: 720: 498:and Vaxchora for 454:hemorrhagic fever 309: 308: 57:Nasdaq Copenhagen 1945: 1742: 1741: 1730: 1723: 1716: 1707: 1706: 1702: 1701: 1699:Official website 1684: 1683: 1681: 1679: 1673: 1660: 1652: 1646: 1645: 1643: 1641: 1620: 1614: 1613: 1611: 1609: 1593: 1587: 1586: 1584: 1582: 1571: 1565: 1564: 1562: 1560: 1549: 1543: 1542: 1540: 1538: 1527: 1521: 1520: 1518: 1516: 1505: 1499: 1498: 1496: 1494: 1489:on 27 March 2020 1488: 1481: 1473: 1467: 1466: 1464: 1462: 1451: 1445: 1444: 1442: 1440: 1426: 1420: 1419: 1417: 1415: 1401: 1395: 1394: 1392: 1390: 1375: 1369: 1368: 1366: 1364: 1353: 1347: 1346: 1344: 1342: 1327: 1321: 1320: 1318: 1316: 1297: 1291: 1290: 1288: 1286: 1263: 1257: 1256: 1254: 1252: 1237: 1231: 1230: 1228: 1226: 1211: 1205: 1200: 1194: 1193: 1183: 1173: 1141: 1135: 1134: 1132: 1130: 1108: 1102: 1096: 1095: 1091: 1089: 1087: 1064: 1058: 1057: 1055: 1053: 1030: 1024: 1023: 1021: 1019: 996: 990: 989: 971: 937: 931: 930: 928: 926: 920: 913: 905: 899: 898: 896: 894: 885:. Archived from 875: 869: 868: 866: 864: 850: 844: 843: 841: 839: 834:on 13 March 2022 824: 815: 814: 812: 806:. Archived from 801: 793: 787: 786: 780: 772: 770: 768: 757: 623:Rabipur/RabAvert 521: 520: 482:and Encepur for 340: 297: 294: 282: 281: 263: 262: 256: 242: 241: 235: 221: 220: 120: 118: 113: 92: 31: 24: 20: 1953: 1952: 1948: 1947: 1946: 1944: 1943: 1942: 1888: 1887: 1886: 1881: 1772:Bavarian Nordic 1753: 1751:(December 2023) 1736: 1734: 1697: 1696: 1693: 1688: 1687: 1677: 1675: 1671: 1658: 1654: 1653: 1649: 1639: 1637: 1622: 1621: 1617: 1607: 1605: 1595: 1594: 1590: 1580: 1578: 1573: 1572: 1568: 1558: 1556: 1551: 1550: 1546: 1536: 1534: 1529: 1528: 1524: 1514: 1512: 1507: 1506: 1502: 1492: 1490: 1486: 1479: 1475: 1474: 1470: 1460: 1458: 1453: 1452: 1448: 1438: 1436: 1428: 1427: 1423: 1413: 1411: 1403: 1402: 1398: 1388: 1386: 1376: 1372: 1362: 1360: 1355: 1354: 1350: 1340: 1338: 1329: 1328: 1324: 1314: 1312: 1299: 1298: 1294: 1284: 1282: 1265: 1264: 1260: 1250: 1248: 1239: 1238: 1234: 1224: 1222: 1213: 1212: 1208: 1201: 1197: 1156:(6): e0157335. 1142: 1138: 1128: 1126: 1110: 1109: 1105: 1093: 1085: 1083: 1066: 1065: 1061: 1051: 1049: 1048:on 20 June 2018 1038:Human Medicines 1032: 1031: 1027: 1017: 1015: 1014:on 17 June 2014 998: 997: 993: 938: 934: 924: 922: 921:on 2 April 2024 918: 911: 907: 906: 902: 892: 890: 889:on 17 July 2020 877: 876: 872: 862: 860: 852: 851: 847: 837: 835: 826: 825: 818: 810: 799: 795: 794: 790: 774: 773: 766: 764: 759: 758: 754: 749: 726: 602:Liquid-frozen. 580:Liquid-frozen. 562:Liquid-frozen. 516: 488:GlaxoSmithKline 476: 435: 380: 375: 334: 305: 293:bavarian-nordic 291: 275: 252: 231: 167: 143: 136: 132: 116: 114: 111: 88: 71: 50: 17: 12: 11: 5: 1951: 1941: 1940: 1935: 1930: 1925: 1920: 1915: 1910: 1905: 1900: 1883: 1882: 1880: 1879: 1874: 1872:Zealand Pharma 1869: 1864: 1859: 1854: 1849: 1844: 1839: 1834: 1829: 1824: 1819: 1814: 1809: 1804: 1799: 1794: 1789: 1784: 1779: 1774: 1769: 1764: 1758: 1755: 1754: 1733: 1732: 1725: 1718: 1710: 1704: 1703: 1692: 1691:External links 1689: 1686: 1685: 1647: 1615: 1588: 1566: 1544: 1522: 1500: 1468: 1446: 1421: 1396: 1370: 1348: 1322: 1292: 1258: 1232: 1206: 1195: 1136: 1103: 1059: 1025: 991: 932: 900: 870: 845: 816: 788: 751: 750: 748: 745: 725: 722: 719: 718: 715: 712: 707: 703: 702: 699: 696: 691: 687: 686: 675: 672: 663: 657: 656: 652: 649: 642: 638: 637: 633: 630: 624: 620: 619: 616: 613: 608: 604: 603: 600: 597: 588: 582: 581: 578: 575: 570: 564: 563: 560: 557: 543: 537: 536: 533: 528: 525: 515: 512: 475: 472: 434: 431: 408:European Union 379: 376: 374: 371: 330:, Denmark and 307: 306: 299: 298: 289: 285: 284: 276: 273: 270: 269: 257: 249: 248: 236: 228: 227: 215: 211: 210: 173: 169: 168: 166: 165: 156:Paul Chaplin ( 154: 149:Luc Debryune ( 146: 144: 141: 138: 137: 134: 128: 126: 122: 121: 108: 104: 103: 98: 94: 93: 86: 80: 79: 70: 69: 63: 53: 51: 46: 43: 42: 37: 33: 32: 15: 9: 6: 4: 3: 2: 1950: 1939: 1936: 1934: 1931: 1929: 1926: 1924: 1921: 1919: 1916: 1914: 1911: 1909: 1906: 1904: 1901: 1899: 1896: 1895: 1893: 1878: 1875: 1873: 1870: 1868: 1865: 1863: 1860: 1858: 1857:Royal Unibrew 1855: 1853: 1850: 1848: 1845: 1843: 1840: 1838: 1835: 1833: 1830: 1828: 1825: 1823: 1820: 1818: 1815: 1813: 1812:GN Store Nord 1810: 1808: 1805: 1803: 1800: 1798: 1795: 1793: 1790: 1788: 1785: 1783: 1780: 1778: 1775: 1773: 1770: 1768: 1765: 1763: 1760: 1759: 1756: 1752: 1749: 1746:companies of 1745: 1740: 1731: 1726: 1724: 1719: 1717: 1712: 1711: 1708: 1700: 1695: 1694: 1670: 1666: 1665: 1657: 1651: 1635: 1631: 1630: 1625: 1619: 1604: 1603: 1598: 1592: 1576: 1570: 1554: 1548: 1532: 1531:"Chikungunya" 1526: 1510: 1504: 1485: 1478: 1472: 1456: 1450: 1435: 1434:Fierce Pharma 1431: 1425: 1410: 1406: 1400: 1385: 1381: 1374: 1358: 1352: 1336: 1332: 1326: 1310: 1306: 1302: 1296: 1280: 1276: 1272: 1271:reuters-brief 1268: 1262: 1246: 1242: 1236: 1220: 1216: 1210: 1204: 1199: 1191: 1187: 1182: 1177: 1172: 1167: 1163: 1159: 1155: 1151: 1147: 1140: 1124: 1120: 1118: 1113: 1107: 1100: 1099:public domain 1081: 1077: 1075: 1069: 1063: 1047: 1043: 1039: 1035: 1029: 1013: 1009: 1008:Health Canada 1005: 1001: 995: 987: 983: 979: 975: 970: 965: 961: 957: 953: 949: 948: 943: 936: 917: 910: 904: 888: 884: 880: 874: 859: 855: 849: 833: 829: 823: 821: 809: 805: 798: 792: 784: 778: 762: 756: 752: 744: 742: 738: 733: 731: 716: 713: 711: 708: 705: 704: 700: 697: 695: 692: 689: 688: 684: 680: 676: 673: 671: 670:Marburg virus 667: 664: 662: 659: 658: 653: 650: 647: 643: 640: 639: 634: 631: 629: 625: 622: 621: 617: 614: 612: 609: 606: 605: 601: 598: 596: 592: 589: 587: 584: 583: 579: 576: 574: 571: 569: 566: 565: 561: 558: 555: 551: 547: 544: 542: 539: 538: 534: 532: 529: 526: 523: 522: 519: 511: 509: 505: 501: 497: 496:typhoid fever 493: 489: 485: 481: 471: 468: 465:companies of 464: 461:, one of the 460: 455: 452: 448: 444: 440: 430: 428: 423: 421: 417: 413: 409: 405: 401: 397: 393: 389: 385: 370: 368: 367:viral vectors 364: 360: 356: 352: 348: 344: 338: 333: 329: 325: 321: 317: 316:biotechnology 313: 304: 300: 296: 290: 286: 277: 271: 267: 258: 255: 250: 246: 237: 234: 229: 225: 216: 212: 209: 205: 201: 197: 193: 189: 185: 181: 177: 174: 170: 163: 159: 155: 152: 148: 147: 145: 139: 131: 127: 123: 109: 105: 102: 101:Biotechnology 99: 95: 91: 87: 85: 81: 78: 74: 67: 64: 62: 58: 55: 54: 52: 49: 44: 41: 38: 34: 30: 25: 19: 1837:Novo Nordisk 1771: 1750: 1676:. Retrieved 1662: 1650: 1638:. Retrieved 1627: 1618: 1606:. Retrieved 1600: 1591: 1579:. Retrieved 1569: 1557:. Retrieved 1547: 1535:. Retrieved 1525: 1513:. Retrieved 1503: 1491:. Retrieved 1484:the original 1471: 1459:. Retrieved 1449: 1437:. Retrieved 1433: 1424: 1412:. Retrieved 1408: 1399: 1387:. Retrieved 1383: 1373: 1361:. Retrieved 1351: 1339:. Retrieved 1325: 1313:. Retrieved 1309:the original 1295: 1283:. Retrieved 1270: 1261: 1249:. Retrieved 1245:the original 1235: 1223:. Retrieved 1219:the original 1209: 1198: 1153: 1149: 1139: 1127:. Retrieved 1115: 1106: 1084:. Retrieved 1071: 1062: 1050:. Retrieved 1046:the original 1037: 1028: 1016:. Retrieved 1012:the original 1003: 994: 954:(1): 13–24. 951: 945: 935: 923:. Retrieved 916:the original 903: 891:. Retrieved 887:the original 882: 873: 861:. Retrieved 857: 848: 836:. Retrieved 832:the original 808:the original 803: 791: 765:. Retrieved 761:"Archive.ph" 755: 734: 727: 724:Associations 517: 477: 474:Acquisitions 445:vaccine for 436: 424: 381: 373:Technologies 311: 310: 302: 283:1.379 (2023) 268: (2023) 254:Total equity 247: (2023) 233:Total assets 226: (2023) 125:Headquarters 90:DK0015998017 36:Company type 18: 1832:Nordea Bank 1792:Danske Bank 1782:Chr. Hansen 1439:20 February 1409:www.gsk.com 1384:PharmaTimes 767:8 September 694:Chikungunya 648:(TBE) virus 504:chikungunya 486:(TBE) from 359:Switzerland 347:Martinsried 335: [ 73:OTC Markets 1892:Categories 1822:Jyske Bank 1455:"Pipeline" 1341:12 January 1315:29 October 1285:29 October 1251:29 October 1225:29 October 1129:16 October 1086:16 October 838:6 December 804:Nasdaq OMX 747:References 706:MVA-BN WEV 527:Indication 332:Thörishaus 142:Key people 1842:Novozymes 1787:Coloplast 1777:Carlsberg 1068:"Jynneos" 1034:"Imvanex" 690:CHIKV VLP 443:filovirus 406:, in the 328:Kvistgård 158:president 68:component 66:OMXC25CAP 48:Traded as 1852:Rockwool 1669:Archived 1667:. 2017. 1634:Archived 1335:Archived 1279:Archived 1190:27327616 1150:PLOS ONE 1123:Archived 1080:Archived 986:35854977 978:19093767 777:cite web 679:Zabdeno® 651:Approved 632:Approved 611:Smallpox 591:Smallpox 573:Smallpox 568:Imvamune 554:vaccinia 546:Smallpox 404:Imvamune 392:smallpox 388:vaccinia 320:Hellerup 204:Vaxchora 192:RabAvert 180:Imvamune 172:Products 151:chairman 130:Hellerup 97:Industry 1847:Pandora 1748:Denmark 1640:20 June 1559:15 July 1493:15 July 1461:14 July 1414:3 April 1389:3 April 1363:16 July 1305:AP News 1275:Reuters 1181:4915701 1158:Bibcode 1119:(NIAID) 1052:12 June 1018:26 June 969:9709931 925:8 April 893:8 April 863:8 April 683:Mvabea® 641:Encepur 586:Jynneos 541:Imvanex 535:Remark 524:Product 506:, from 500:cholera 492:Vivotif 451:Marburg 416:Jynneos 412:Imvanex 351:Germany 324:Denmark 288:Website 214:Revenue 200:Vivotif 196:Encepur 188:Rabipur 184:Jynneos 176:Imvanex 135:Denmark 115: ( 107:Founded 59::  1877:Ørsted 1807:Genmab 1797:Demant 1678:7 July 1188:  1178:  984:  976:  966:  661:Mvabea 628:rabies 556:virus 480:rabies 400:Canada 378:MVA-BN 361:, and 208:Mvabea 40:Public 1672:(PDF) 1659:(PDF) 1608:2 May 1581:2 May 1537:2 May 1515:2 May 1487:(PDF) 1480:(PDF) 1076:(FDA) 1072:U.S. 982:S2CID 919:(PDF) 912:(PDF) 811:(PDF) 800:(PDF) 666:Ebola 531:Phase 447:Ebola 439:NIAID 410:, as 341:near 339:] 77:BVNRY 1862:Tryg 1762:Ambu 1680:2022 1642:2022 1610:2024 1583:2024 1561:2020 1539:2024 1517:2024 1495:2020 1463:2020 1441:2023 1416:2020 1391:2020 1365:2020 1343:2015 1317:2014 1287:2014 1253:2014 1227:2014 1186:PMID 1131:2019 1088:2019 1054:2016 1020:2014 974:PMID 927:2024 895:2024 865:2024 840:2021 783:link 769:2023 668:and 595:mpox 593:and 550:mpox 494:for 449:and 396:mpox 394:and 343:Bern 295:.com 160:and 117:1994 110:1994 84:ISIN 61:BAVA 1827:NKT 1817:ISS 1802:DSV 1176:PMC 1166:doi 964:PMC 956:doi 698:III 615:III 402:as 355:Zug 266:kr. 245:kr. 224:kr. 162:CEO 1894:: 1661:. 1632:. 1626:. 1599:. 1432:. 1407:. 1382:. 1303:. 1273:. 1269:. 1184:. 1174:. 1164:. 1154:11 1152:. 1148:. 1114:. 1070:. 1040:. 1036:. 1006:. 1002:. 980:. 972:. 962:. 950:. 944:. 883:BN 881:. 858:BN 856:. 819:^ 802:. 779:}} 775:{{ 743:. 548:, 510:. 357:, 349:, 337:de 322:, 206:, 202:, 198:, 194:, 186:, 182:, 178:, 133:, 75:: 1729:e 1722:t 1715:v 1682:. 1644:. 1612:. 1585:. 1563:. 1541:. 1519:. 1497:. 1465:. 1443:. 1418:. 1393:. 1367:. 1345:. 1319:. 1289:. 1255:. 1229:. 1192:. 1168:: 1160:: 1133:. 1101:. 1090:. 1056:. 1022:. 988:. 958:: 952:8 929:. 897:. 867:. 842:. 785:) 771:. 714:I 190:/ 164:) 153:) 119:)

Index


Public
Traded as
Nasdaq Copenhagen
BAVA
OMXC25CAP
OTC Markets
BVNRY
ISIN
DK0015998017
Biotechnology
Hellerup
chairman
president
CEO
Imvanex
Imvamune
Jynneos
Rabipur
RabAvert
Encepur
Vivotif
Vaxchora
Mvabea
kr.
Total assets
kr.
Total equity
kr.
bavarian-nordic.com

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.